- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03832270
Support for PARents of Children Living With ADHD - a Research Trial (SPARCLAR)
SPARCLAR: A Feasibility Randomised Controlled Trial of a Parenting Support Programme Focussed on Families Affected by ADHD
Study Overview
Status
Intervention / Treatment
Detailed Description
Attention-Deficit/Hyperactivity Disorder (ADHD) is a chronic and pervasive disorder characterised by problems in attention, impulse control and activity regulation that substantially burdens patients, families, and society. ADHD is often associated with challenging behaviours that can induce negativity, even in parents who would otherwise cope well.The efficacy of behavioural training for parents of children with ADHD symptoms is well established, however it is less clear which type of parenting intervention should be offered, and which aspects of parenting behaviour to focus on. It is not established whether an intervention designed specifically for families of children with a diagnosis will be more effective and cost effective than less specifically-targeted interventions.
Parents In Control (Parents InC) offers specific support around empowerment, information and behaviour management specific to ADHD, as well as understanding of the child's development context. Parents InC has been used for a number of years in Scotland and has been evaluated, with promising results, but with relatively small sample sizes, no long-term follow-up, no economic evaluation and, most crucially, no comparison to an alternative intervention or to a control group. The investigators now need to understand if it: i) is at least as effective as the current best-evidenced alternative, Incredible Years, in impacting children's behaviour outcomes; ii) is cost-effective; and iii) offers something helpful and unique compared to other parenting programmes in terms of parenting self-competence and quality of life.
The purpose of this study is to determine the feasibility and likely size of a substantive randomised controlled trial comparing an ADHD specific parenting intervention to a diagnostically less-specific parenting intervention (Incredible Years). Specific objectives are to test (1) whether parents of children recently diagnosed with ADHD are willing to be randomised to Parents InC or IY; (2) whether sufficient numbers of families can be (a) recruited and (b) retained such that a full-scale RCT is likely to be feasible; (3) whether research procedures and efficacy measures are feasible and acceptable to participating families (including health economic measures and consent to link to routine datasets); (4) whether families participating in Parents InC achieve similar scores on the parenting sense of competence scale at 12 months post randomisation as those in the comparison arm (Incredible Years); (5) Whether the two intervention arms significantly differ on any other measures; and (6) the mean cost per participant of Parents InC.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Fiona Sim
- Phone Number: 01413308254
- Email: sparclar@glasgow.ac.uk
Study Contact Backup
- Name: Fatene Abakar Ismail
- Phone Number: 01413308254
- Email: sparclar@glasgow.ac.uk
Study Locations
-
-
Scotland
-
Dunfermline, Scotland, United Kingdom, KY11 4UW
- Recruiting
- NHS Fife Psychology Department
-
Contact:
- Hilary Maddox, Dr
- Phone Number: 01383565400
- Email: hilarymaddox@nhs.net
-
Contact:
- Caroline Hollinsworth
- Phone Number: 01383 565400
- Email: carolinehollinsworth@nhs.net
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
• Parents of children aged 5-12 with a formal diagnosis of ADHD, following a standardised assessment from a paediatrician or a psychiatrist, referred to the Fife integrated ADHD pathway during the one year recruitment period will be eligible for inclusion.
Exclusion Criteria:
- Families attending other parenting groups
- Parents who have low proficiency in English (as this will compromise their ability to complete research measures or participate in a group intervention).
- Participants already taking part in research on a parenting intervention will also be ineligible to participate.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Parents InC
Group parenting support intervention based around four pillars: 1) empowerment/ownership; 2) education on ADHD and its effect on family identity/ values; 3) positive parenting in the context of ADHD; 4) making sense of ADHD in a developmental context.
It is delivered over 5 weekly 2-hour sessions, a 6 week break, and a follow-up session.
|
Based on social learning theory, Parents InC has been designed specifically for parents of children with an ADHD diagnosis with a particular focus on parenting sense of self competence.
|
ACTIVE_COMPARATOR: Incredible Years
A group parenting support intervention aimed at strengthening parent-child interactions and attachment, reducing harsh discipline and fostering parents' ability to promote children's social, emotional, and academic development.
The IY programme is delivered over 14 weekly 2-hour sessions.
IY facilitators are videotaped during sessions to maintain intervention fidelity.
IY also includes 1-4 pre-intervention preparation sessions which may involve home visits and telephone support and reminders.
|
Also based on social learning theory but focus is not specifically on ADHD.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of parents willing to be randomised to Parents InC or Incredible Years.
Time Frame: Continuous over 1 year study period
|
Measured by number of parents agreed to randomisation throughout the study period.
|
Continuous over 1 year study period
|
Number of parents recruited and retained.
Time Frame: Continuous over 1 year study period
|
Measured by number of parents recruited and retained throughout the study period.
|
Continuous over 1 year study period
|
Research procedures feasibility and acceptability
Time Frame: Continuous over 1 year study period
|
Face to face interviews will be conducted with participating families to assess the feasibility and acceptability of research procedures.
|
Continuous over 1 year study period
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Primary efficacy outcome: Parental Sense of Competence Scale.
Time Frame: Baseline, 12-months post-randomisation
|
17-items measure of parenting self-esteem questionnaire with 2 sub scales.
Each item is rated on a 6 point Likert scale anchored by 1= "Strongly Disagree" and 6= "Strongly Agree".
A higher score indicates a higher parenting sense of competency.
There are no average scores or 'cut-off's' for this tool.
|
Baseline, 12-months post-randomisation
|
Eyberg Child Behaviour Inventory.
Time Frame: Baseline, 12-month post-randomisation
|
36-items measure (parent reported) that assesses the current frequency and severity of child's behaviour.
Items are rated on a 7-point intensity scale and a yes/no Problem scale.
|
Baseline, 12-month post-randomisation
|
General Health Questionnaire.
Time Frame: Baseline, 12-month post-randomisation
|
12-items self-report measure of common psychiatric conditions of parents.
Each item is accompanied with four responses; "Not at all", "No more than usual", "Rather more than usual" and "Much more than usual".
Items are rated on a 4-point response scale.
|
Baseline, 12-month post-randomisation
|
ADHD Symptom Rating Scale-Version 1.
Time Frame: Baseline, 12-month post-randomisation
|
Self-report symptom checklist consisting of 18 DSM-IV criteria for parents.
The checklist assesses occurrence frequency of each symptom.
|
Baseline, 12-month post-randomisation
|
Parenting Daily Hassles Scale.
Time Frame: Baseline, 3 months post Baseline (if applicable), 12-month post-randomisation
|
18-items self-report measure of the frequency and intensity of 20 potential parenting 'hassles' to indicate parents stress.
The items are rated on a frequency and intensity scale.
The frequency scale is scored rarely =1, sometimes= 2, a lot= 3, and constantly = 4.
The intensity scale is scored by adding the parents rating of 1-5 for each item.
If a 0 has been scored for frequency on an item then it should be scored 0 for intensity.
The range for this scale is 0 -100.
This measure will be re-collected if there is > 3 months wait period between baseline data collection and the start date of the parenting groups.
This will allow the investigators to detect any baseline measure changes over the wait period.
|
Baseline, 3 months post Baseline (if applicable), 12-month post-randomisation
|
Goal Based Outcomes.
Time Frame: Baseline, 3 months post Baseline (if applicable), 12-month post-randomisation
|
Taken from the Child Outcomes Research Consortium to identify goals and assess progression.
Progress toward individual goal is rated on a scale from 0 (no progress) to 10 (goal has been reached).
This measure will be re-collected if there is > 3 months wait period between baseline data collection and the start date of the parenting groups.
This will allow the investigators to detect any baseline measure changes over the wait period.
|
Baseline, 3 months post Baseline (if applicable), 12-month post-randomisation
|
EQ-5D-5L
Time Frame: Baseline, 3 months post Baseline (if applicable), 12-month post-randomisation
|
Self-report measure of parent quality of life.
The EQ-5D-5L is a descriptive system comprises 5 dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression.
Each dimension has 5 levels: no problems, slight problems, some problems, moderate problems, extreme problems.
Parents will be also be asked to rate their health on a visual analogue scale.
This measure will be re-collected if there is > 3 months wait period between baseline data collection and the start date of the parenting groups.
This will allow the investigators to detect any baseline measure changes over the wait period.
|
Baseline, 3 months post Baseline (if applicable), 12-month post-randomisation
|
Paediatric Quality of Life Inventory (PedsQL)
Time Frame: Baseline, 12-month post-randomisation
|
23-items questionnaire which covers 4 core dimensions (physical, social, emotional and school functioning).
Each dimension has 4 levels: never = 0, almost never= 1, sometimes= 2, often= 3 and almost always= 4.
|
Baseline, 12-month post-randomisation
|
Strengths and Difficulties Questionnaire (SDQ)
Time Frame: Baseline, 3 months post Baseline (if applicable), 12-month post-randomisation
|
25-items questionnaire which assesses child's emotional and behavioural problems.
Each item is scored 0, 1 or 2. Somewhat true is always scored 1, but whether Not true and Certainly true are scored 0 or 2 depends on whether the item is framed as a strength or difficulty.
This measure will be re-collected if there is > 3 months wait period between baseline data collection and the start date of the parenting groups.
This will allow the investigators to detect any baseline measure changes over the wait period.
|
Baseline, 3 months post Baseline (if applicable), 12-month post-randomisation
|
Participant service use
Time Frame: 12-month post-randomisation
|
Measured using diaries
|
12-month post-randomisation
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Lucy Thompson, University of Glasgow
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HIPS/17/58
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Attention Deficit Disorder With Hyperactivity
-
Ornit CohenUnknownAttention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | Attention Deficit Disorder | Attention Deficit Disorders With Hyperactivity | Attention Deficit Hyperactivity DisordersIsrael
-
Cingulate TherapeuticsRecruitingPhase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301ADHD | Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Karolinska InstitutetCompletedAttention Deficit Disorder With Hyperactivity (ADHD)Sweden
-
Fondation LenvalCompletedAttention Deficit Disorder With Hyperactivity | Attention Deficit Disorder Without HyperactivityFrance
-
Rabin Medical CenterNG Solutions LtdRecruitingADHD - Attention Deficit Disorder With HyperactivityIsrael
-
Clinical and Translational Genome Research Institute...Children's Specialized HospitalTerminatedAttention Deficit Disorders With HyperactivityUnited States
-
University of PennsylvaniaCompletedAttention Deficit Disorder With Hyperactivity (ADHD)United States
-
Nemours Children's ClinicCompletedAttention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | Attention Deficit DisorderUnited States
-
Massachusetts General HospitalRecruitingAttention Deficit Disorder With Hyperactivity | Attention Deficit DisorderUnited States
-
New River PharmaceuticalsShireCompletedAttention Deficit Hyperactivity Disorder | Attention Deficit Disorders With Hyperactivity | Attention Deficit Hyperactivity DisordersUnited States
Clinical Trials on Parents InC
-
New York UniversityNot yet recruitingChild Sexual AbuseUnited States
-
Université Libre de BruxellesCompletedParents | Dental Anxiety | Behavior, ChildBelgium
-
Nagano Children's HospitalActive, not recruiting
-
Penn State UniversityCompleted
-
USDA, Delta Human Nutrition Research ProgramCompleted
-
Centre for Addiction and Mental HealthOntario Ministry of Community and Social ServicesCompleted
-
Duke UniversityInternational Rescue CommitteeCompleted
-
Washington University School of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedObesity | Pregnancy | Weight GainUnited States
-
University Hospital of North NorwayNorwegian Council for Mental Health; University of Tromso; The Research Council... and other collaboratorsCompleted
-
Mahidol UniversityUnknownFoot Deformity CongenitalThailand